University of Florida
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).
University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.
University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.
Top-decile sponsor footprint
University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,106 total, page 19 of 23
Prevalence, Persistence, and Risk Factors for Oral Human Papillomavirus (HPV) Infections in College Women
NCT01289873
Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation
NCT01339572
Respiratory Muscle Strength and Function in Healthy Kids
NCT01436318
Respiratory Muscle Strength in Patients With NMD
NCT01555905
Ankle Fracture Treatment in the Elderly
NCT01444144
Intervertebral Disc Augmentation With Minimally Invasive Surgical Procedure
NCT01442922
Do Hip Injections Improve Short-Term Biomechanical Outcomes In Patients With Hip Pain
NCT01390103
Effects Of Not Measuring Gastric Residual Content On Feeding Tolerance In Premature Infants iNFANTS
NCT01965769
Practicality of Intermittent Fasting and Its Effect on Markers of Aging and Oxidative Stress
NCT02132091
Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.
NCT01291017
A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS
NCT01085656
The Effect Of Wound Irrigation With Irrisept™ Delivery System On Abscess Healing In Patients Presenting To The Emergency Department
NCT01302548
Do Lower Spine Injections Improve Outcomes for Lower Back Pain Patients
NCT01381224
Cough and Swallow Rehab Following Stroke
NCT01907321
Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)
NCT01203787
Resistance Exercise Effects on Fear Avoidance and Physical Function in Obese Older Adults With Low Back Pain
NCT01250262
Will Having Alcohol Treatment Improve Functioning?
NCT01245647
Resistance Exercise and Knee Osteoarthritis Pain, Functional Impairment and Cartilage Turnover
NCT01245283
Intraarticular Lumbar Joint Corticosteroid Injection(s) as a Treatment of Chronic Low Back Pain in a Selected Population
NCT01382771
Radioactive Iodide Therapy for Pediatric Graves' Disease
NCT01269749
Galactooligosaccharide, Immune Strength, and Digestive Health in Older Adults Over Cold and Flu Season
NCT01302561
Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor
NCT01326104
Safety Study of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase to Treat Pompe Disease
NCT00976352
Clinical Trials to Reduce the Risk of Antimicrobial Resistance
NCT01570192
Prasugrel Re-load Strategies
NCT01201772
Retrospective Analysis of Treatment Outcomes in Patients With Bacterial Overgrowth Syndrome Diagnosed by D-Xylose Breath Testing
NCT01324895
Effects of Treating Vitamin D Deficiency in Poorly Controlled Type 2 Diabetes
NCT01855321
Pharmacogenomic Evaluation of Antihypertensive Responses 2
NCT01203852
Locomotor Adaptation Training to Prevent Mobility Disability
NCT02554916
Nebivolol Effect on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients
NCT01157234
Fluid Balance and Clinical Outcomes
NCT01168583
Long Term Antihypertensive Exposure and Adverse Metabolic Effects: PEAR Follow-Up Study
NCT01409434
Blood Flow, Muscle Regeneration and Sarcopenia
NCT01035060
Study of the Health Information Needs of Brain Cancer Patients
NCT01130220
Effect of Inspiratory Muscle Training on Duration of Mechanical Ventilation Support
NCT01108575
Wheat Bioactives and Immune Function
NCT02210234
Autologous Fat Transfer for Scar Prevention and Remodeling
NCT01119326
The Effects of Fiber Fortified Foods to the Diets of Chronic Kidney Disease Patients
NCT01842087
Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors
NCT01111097
Task Specific Exercise for the Prevention of Disability
NCT01183507
Does Nesiritide Provide Renal Protection
NCT01440881
Reversing Type 1 Diabetes After it is Established
NCT01106157
Vitamin B6 Effects for Women Taking Birth Control Pills
NCT01128244
Pharmacotoxicology of Trichloroethylene Metabolites
NCT01128270
Minimally Invasive Surgical Treatment Versus Medical Management for Stroke Patients With Atrial Fibrillation
NCT01442181
Newborn Screening for Critical Congenital Heart Disease
NCT01765205
Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS)
NCT01327300
Semen Analysis After Proton Therapy for Prostate Cancer
NCT01072513
The Effect of Aged Garlic Extract Supplementation on Immune System
NCT01390116
Outcomes Study of Late Effects After Proton RT for Pediatric Tumors of the Brain, Head, and Neck
NCT01067196
What is open in the University of Florida pipeline
170 recruiting of 1,106 indexed (15% open); 754 completed (68%).
Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Coronary Artery Disease (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Florida: open-pipeline peers nationwide
Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,106 trials (± recruiting share)
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this University of Florida page
1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.
- 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Florida pipeline card: 1,106 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.